文献速递呼吸道感染

实体器官移植受者社区获得性肺炎的临床特征、诊断、病因与结局

Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis.
PubMed 文献 · Chest · 2024-05-30

该回顾性队列分析德国最大移植中心2010至2021年403例次实体器官移植受者CAP住院,发现院内死亡率13.2%、1年死亡率24.6%,心血管事件发生率高,早期血培养和支气管镜可提高病原检出率,耐药负担主要来自慢性定植患者。

要点

  • 移植受者CAP院内死亡率13.2%,1年死亡率24.6%。
  • 入院24小时内血培养和支气管镜可提高病原检出率。
  • 耐药菌负担主要来自慢性定植患者,多为肺移植受者。

核心结论

  • 实体器官移植受者发生CAP后急性及长期死亡率高、心血管事件发生率高,需前瞻性多中心研究指导循证实践。

研究设计与样本

  • 回顾性分析德国最大移植中心2010年1月1日至2021年5月31日实体器官移植受者CAP住院数据,共403例次住院、333例受者。

主要发现

  • 超过60%病例有多种合并症,最常见为心血管疾病和慢性肾病。
  • 超过半数患者入院后需要氧疗。
  • 院内死亡率为13.2%,事件后1年死亡率为24.6%,均高于免疫正常患者报告的数据。
  • 急性心血管事件及入院1年后事件发生率均高。
  • 入院24小时内早期血培养和支气管镜显著增加确定病因的比值比。

关键数值与推荐

  • 采用多因素二元logistic回归(逐步向前选择法)确定铜绿假单胞菌肺炎的预测因素。
  • 在低耐药环境中,抗菌药物耐药负担由慢性定植患者的细菌驱动,主要为肺移植受者。

临床怎么用

  • 对移植受者CAP应早期行血培养和支气管镜以明确病原。
  • 需关注移植受者CAP后的心血管事件及长期死亡风险。
  • 对慢性定植患者(尤其肺移植受者)应警惕耐药菌感染。

局限性

  • 为单中心回顾性分析,结果外推需谨慎。
  • 原文指出需前瞻性多中心研究指导循证实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Limited evidence is available on the most effective diagnostic approaches, management strategies, and long-term outcomes for CAP in patients who have undergone solid organ transplantation. RESEARCH QUESTION: What is the acute and long-term morbidity and mortality after CAP in organ transplant recipients? STUDY DESIGN AND METHODS: We retrospectively analyzed hospitalizations for CAP in solid organ recipients at the largest German transplant center. The study included patients admitted between January 1, 2010, and May 31, 2021. The reported outcomes are in-hospital and 1-year mortality, risk of cardiovascular events during hospitalization and at 1 year, admission to the ICU, and risk of pneumonia with Pseudomonas aeruginosa. Multivariable binary logistic regression using stepwise forward selection was performed to determine predictive factors for pneumonia with P aeruginosa. RESULTS: We analyzed data from 403 hospitalizations of 333 solid organ recipients. In > 60% of cases, patients had multiple comorbidities, with cardiovascular and chronic kidney disease being the most prevalent. More than one-half of the patients required oxygen supplementation after admission. In-hospital mortality (13.2%) and the death rate at 1 year postevent (24.6%) were higher than data reported from immunocompetent patients. We also observed high rates of acute cardiovascular events and events occurring 1 year after admission. Early blood cultures and bronchoscopy in the first 24 h significantly increased the odds of establishing an etiology. In our low-resistance setting, the burden of antimicrobial resistance was driven by bacteria from chronically colonized patients, mostly lung transplant recipients. INTERPRETATION: This comprehensive analysis highlights the high morbidity associated with CAP after transplantation. It also emphasizes the need for prospective multicenter studies to guide evidence-based practices and improve outcomes for these vulnerable patients.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Joean, von Eynern, Welte, et al. Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis. Chest. 2024. PMID: 38823578. doi:10.1016/j.chest.2024.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。